News
Vista Pharmaceuticals reports standalone net loss of Rs 2.59 crore in the September 2025 quarter
14-Nov-2025 | 13:45
Sales decline 41.37% to Rs 1.46 crore
Net Loss of Vista Pharmaceuticals reported to Rs 2.59 crore in the quarter ended September 2025 as against net loss of Rs 0.97 crore during the previous quarter ended September 2024. Sales declined 41.37% to Rs 1.46 crore in the quarter ended September 2025 as against Rs 2.49 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 1.46 | 2.49 | -41 |
| OPM % | -234.93 | -33.33 | - |
| PBDT | -3.42 | -1.07 | -220 |
| PBT | -3.62 | -1.25 | -190 |
| NP | -2.59 | -0.97 | -167 |
Powered by Capital Market - Live News